Molecular Templates, Inc.

NASDAQ:MTEM

1.34 (USD) • At close September 18, 2024
Bedrijfsnaam Molecular Templates, Inc.
Symbool MTEM
Munteenheid USD
Prijs 1.36
Beurswaarde 8,954,077
Dividendpercentage 0%
52-weken bereik 1 - 6.93
Industrie Biotechnology
Sector Healthcare
CEO Dr. Eric E. Poma Ph.D.
Website https://www.mtem.com

An error occurred while fetching data.

Over Molecular Templates, Inc.

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an

Vergelijkbare Aandelen

Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

BDTX

4.78 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.14 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

27.62 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.678 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.3 USD

Purple Biotech Ltd. logo

Purple Biotech Ltd.

PPBT

6.98 USD

Solid Biosciences Inc. logo

Solid Biosciences Inc.

SLDB

8 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)